Press release
Oncology Biosimilars Market to collect US$17,478.2 mn by 2025
Read Report Overview: https://www.transparencymarketresearch.com/oncology-biosimilars-market.html
Besides this, leading pharmaceutical companies are entering into strategic alliances with leading generic manufacturers to develop biosimilars. A case in point is Biocon. The company entered into a strategic collaboration with Mylan to develop a strong portfolio of biosimilars, including recombinant proteins and monoclonal antibodies.
Cancer is considered the second-leading cause of death worldwide, says an analyst at TMR. Driven by the need to develop affordable treatment options for cancer, and various other factors, the global oncology biosimilars market is projected to expand at a phenomenal CAGR of 27.5% for the forecast period between 2017 and 2025. At this pace, the market that stood at US$2,100 mn in 2016 will become US$17,478.2 mn by the end of 2025.
Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14696
The G-CSF drug class segment led the market in 2016 in terms of revenue, and is anticipated to remain dominant over the forecast period. The growth of this segment is attributed to strong pipeline portfolio of key players in the biosimilars market. Hospital pharmacy led amongst key distribution channels in 2016 vis-à-vis revenue and the trend is expected to continue until the end of the forecast period in 2025.
Asia Pacific is a significant market for oncology biosimilars. A robust pipeline of biosimilars of key players in India, and practices of strategic alliances for the development and commercialization of biosimilars is expected to fuel the growth of Asia Pacific oncology biosimilars market.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14696
Demand for Affordable Therapies for Cancer Aids Growth
Majorly fuelling the growth of oncology biosimilars market is the need to develop affordable therapies for the treatment of cancer. This is because cancer is presently the costliest health affair in terms of diagnosis as well as treatment. Pharmaceutical companies across the world are focused on developing biosimilars and generic medicines to combat cancer at all stages and for early detection of all types of malignancies.
Oncology biosimilars are officially approved versions of oncology biologics that are cost-effective with similar efficacy and potency as original reference biologic. They differ from biologics in terms of manufacturing process and complexity, and can also be manufactured after the patent expiration of original reference biologic. This, along with a robust pipeline of biosimilars is expected to generate promising opportunities for the market in the next few years.
In Europe and Asia, Non-Hodgkin and neutropenia are the major disorders where oncology biosimilars are used. Apart from this, various biosimilars are in the pipeline for the treatment of breast cancer and lung cancer.
Long Approval Process for Biosimilars Deters Growth
On the flip side, need for a complex infrastructure for the production of biosimilars and a lengthy process for biosimilars to receive approval from regulatory bodies are proving to be a roadblock to the market’s growth.
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Biosimilars Market to collect US$17,478.2 mn by 2025 here
News-ID: 986455 • Views: …
More Releases from TMR - Research Report
Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Overview
The global tissue extraction system market is foretold to display an impressive growth rate in the coming years. This could be owing to the need for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of…
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Anal …
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local…
External Fixator Devices Market: Global Survey and Trend Research
External fixator devices are used to stabilize and support long bone open fractures to help the patient carry body’s weight as well as movement. Schanz screws, connecting rods, and clamps are used in case of unipolar external fixators. Circulatory fixators include circular rings, wires, connecting rods, and struts. The external fixator devices provide rigid fixation along with fixed distraction of the fracture fragments. The major advantage of external fixator devices…
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal preparations are products that contain a combination of an anti-inflammatory agent, or a pain reliever, and a local anesthetic as a suppository, or an ointment. External or internal hemorrhoids are treated by the topical application of anorectal preparations. Hemorrhoids are masses or lumps of tissue in the anus that contain enlarged blood vessels. The formation of hemorrhoids is due to an increase in abdominal pressure. Frequent constipation, which is…
More Releases for US$17
Bioplastics Packaging Market to Surpass US$ 17 Bn by 2031
A newly updated report by Persistence Market Research projects the global market for bioplastics packaging to pull in revenue of US$ 17 Bn by 2031. The market is anticipated to attain this value by clocking a phenomenal CAGR of 14% from 2021 and 2031.
A small number of companies operate in the global market for bioplastics packaging, and competition among them is intense. A noticeable trend in the market is the…
Conformal Coatings Market to Cross US$ 17 Bn by 2030
Albany, NY - Conformal Coatings Market: Introduction
In terms of value, the global conformal coatings market is anticipated to expand at a CAGR of ~5% from 2020 to 2030 and cross US$ 17 Bn by 2030. Asia Pacific dominated the global conformal coatings market in terms of value in 2019. It is estimated to be the leading region of the global conformal coatings market during the forecast period. The aerospace industry…
Sports Supplements Market to Approach US$ 17 Bn by 2025
Persistence Market Research (PMR), in its recent outlook titled, “Sports Supplements Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025”, has presented revised forecasts of the global sports supplements market that covers various angles necessary to gauge the market scenario in the present timeline as well as few years down the line. The reader can assess the market and can prioritize his moves basis the intelligence and actionable insights provided in…
Global Hemophilia Treatment Market US$ 17 Billion by 2023
The global hemophilia treatment market to attain US$ 17 Billion by 2023, growing at a CAGR of 5.5% over the forecast period.
While less than 1 million people suffer from hemophilia A or B globally, they are among some of the most costly patients to treat because of frequent transfusions, costly medicines and often have a poor health prognosis, particularly in the absence of treatment. There are ~39,000 patients with haemophilia…
Phenol Market Will Surpass US$ 17 Bn by 2025
Phenol is an aromatic compound commonly known as carbolic acid that has a similar structure to alcohol but with higher levels of acidity. The global phenol market is driven in large part by the surging demand for bisphenol – A.
The demand in the global phenol market is substantially influenced by general macroeconomic factors and thus, the consumption of phenol has a direct relation to the growth patterns of major…
Phenol Market to Touch US$ 17 Billion by 2022
The companies profiled in the phenol market report include ALTIVIA Chemicals, Ineos Group Limited, Domo Investment Group, Deepak Nitrite Limited, CEPSA Química, PTT Global Chemical Public Company Limited, Solvay SA, Mitsui Chemicals, AdvanSix Inc., and Royal Dutch Shell
Phenol is an aromatic compound commonly known as carbolic acid that has a similar structure to alcohol but with higher levels of acidity. The global phenol market is driven in large part by…
